Curis
CRIS
#11077
Rank
โ‚ฌ4.15 M
Marketcap
0,62ย โ‚ฌ
Share price
-23.04%
Change (1 day)
-45.25%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -โ‚ฌ7.6 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ4.31 Million. In 2025 the company made an earning of -โ‚ฌ4.81 Million, an increase over its 2024 earnings that were of -โ‚ฌ38.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ7.6 Million57.92%
2025 -โ‚ฌ4.81 Million-87.38%
2024 -โ‚ฌ38.1 Million-5.77%
2023 -โ‚ฌ40.44 Million-13.1%
2022 -โ‚ฌ46.53 Million27.52%
2021 -โ‚ฌ36.49 Million65.09%
2020 -โ‚ฌ22.11 Million-9.1%
2019 -โ‚ฌ24.32 Million-4.73%
2018 -โ‚ฌ25.52 Million-41.95%
2017 -โ‚ฌ43.96 Million-14.37%
2016 -โ‚ฌ51.34 Million3.55%
2015 -โ‚ฌ49.58 Million271.52%
2014 -โ‚ฌ13.35 Million76.64%
2013 -โ‚ฌ7.56 Million
2011 -โ‚ฌ6.42 Million27.76%
2010 -โ‚ฌ5.03 Million-43.87%
2009 -โ‚ฌ8.95 Million-23.44%
2008 -โ‚ฌ11.69 Million56.66%
2007 -โ‚ฌ7.46 Million-16.71%
2006 -โ‚ฌ8.96 Million-36.92%
2005 -โ‚ฌ14.2 Million156.25%
2004 -โ‚ฌ5.55 Million-37.24%
2003 -โ‚ฌ8.83 Million-93.34%
2002 -โ‚ฌ0.14 Billion86.79%
2001 -โ‚ฌ70.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.15 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.09 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ55.12 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.94 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.3 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ19.83 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚ฌ84.71 Million 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA